原発性大腸がんと同期性およびメタクロン性転移の遺伝的違い
Marie Rajtmajerova1, Filip Ambrozkiewicz1, Viktor Hlavac2,3
1Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
International journal of cancer
|August 30, 2025
まとめ
結腸直腸がん (CRC) の肝臓転移における遺伝的差異の調査は,明確な変異パターンを明らかにした. これらの遺伝的変異は腫瘍の進行と患者の生存に影響を及ぼし,同期性およびメタクロン性転移の異なる経路を示唆する.
科学分野:
- 腫瘍学
- 遺伝学
- 癌 研究
背景:
- 結腸直腸がん (CRC) は,世界中でがんによる死亡の主な原因です.
- 転移性疾患は,CRCに関連する死亡の主な要因です.
- 肝臓転移の遺伝的違いを理解することは 診断と予後を改善するために不可欠です
研究 の 目的:
- 肝臓転移の同期型とメタクロン型の結腸直腸がん患者の遺伝的違いを特定する.
- 主要腫瘍とペア肝転移の変異型,レベル,複製数の変化を分析する.
- 遺伝子の相互作用と腫瘍の慢性化と患者の生存との関連を調査する.
主な方法:
- 210人の患者サンプル (原発性腫瘍とペア化した肝臓転移) の全エクソームシーケンシング
- 変異プロファイルと複製数の変化の分析
- シンクロンとメタクロンメタスタティックコホート間の比較遺伝分析.
主要な成果:
- APCとTP53は最も頻繁に変異した遺伝子でした.
- シンクロン対メタクロン転移 (例えば,MPDZ,VCAN,FBN1) と関連した原発性腫瘍で明確な変異パターンが観察されました.
- 変異遺伝子の間の差異的遺伝子の相互作用は,転移の慢性性に基づいて特定されました.
結論:
- 異なる腫瘍進行経路は,大腸がんの転移の慢性化に寄与する.
- 肝臓転移の遺伝的差異は,患者の生存結果と相関しています.
- 基礎となるメカニズムを解明するために,トランスクリプトミクスとエピジェノミクスデータを組み込むさらなる研究が必要である.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


